Public Employees Retirement System of Ohio Increases Stock Holdings in HCA Healthcare Inc (NYSE:HCA)

Public Employees Retirement System of Ohio grew its position in HCA Healthcare Inc (NYSE:HCA) by 13.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 283,694 shares of the company’s stock after buying an additional 34,677 shares during the quarter. Public Employees Retirement System of Ohio owned 0.08% of HCA Healthcare worth $38,347,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of HCA. Westside Investment Management Inc. acquired a new stake in HCA Healthcare in the 2nd quarter worth about $34,000. NEXT Financial Group Inc purchased a new position in shares of HCA Healthcare in the 2nd quarter worth about $43,000. Rational Advisors LLC raised its holdings in shares of HCA Healthcare by 5,118.2% in the 1st quarter. Rational Advisors LLC now owns 574 shares of the company’s stock worth $75,000 after purchasing an additional 563 shares during the period. Cornerstone Advisors Inc. raised its holdings in shares of HCA Healthcare by 19.6% in the 1st quarter. Cornerstone Advisors Inc. now owns 587 shares of the company’s stock worth $77,000 after purchasing an additional 96 shares during the period. Finally, Alpha Windward LLC raised its holdings in shares of HCA Healthcare by 50.9% in the 2nd quarter. Alpha Windward LLC now owns 608 shares of the company’s stock worth $89,000 after purchasing an additional 205 shares during the period. 70.32% of the stock is currently owned by institutional investors and hedge funds.

Shares of NYSE:HCA traded up $1.85 during mid-day trading on Friday, hitting $126.10. 1,443,132 shares of the company traded hands, compared to its average volume of 1,363,908. The firm has a market cap of $42.37 billion, a P/E ratio of 12.91, a PEG ratio of 1.06 and a beta of 0.87. HCA Healthcare Inc has a 52-week low of $110.31 and a 52-week high of $147.42. The firm’s 50 day simple moving average is $128.11 and its 200 day simple moving average is $129.59.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 30th. The company reported $2.21 EPS for the quarter, missing the consensus estimate of $2.49 by ($0.28). The company had revenue of $12.60 billion for the quarter, compared to analysts’ expectations of $12.61 billion. HCA Healthcare had a net margin of 7.46% and a negative return on equity of 135.90%. The business’s quarterly revenue was up 9.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.29 earnings per share. On average, equities analysts expect that HCA Healthcare Inc will post 10.4 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Tuesday, September 3rd will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, August 30th. This represents a $1.60 annualized dividend and a dividend yield of 1.27%. HCA Healthcare’s payout ratio is currently 16.38%.

In related news, major shareholder Patricia F. Elcan bought 250 shares of the company’s stock in a transaction that occurred on Tuesday, August 6th. The shares were acquired at an average cost of $124.10 per share, for a total transaction of $31,025.00. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Robert A. Waterman sold 33,786 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $134.98, for a total value of $4,560,434.28. Following the sale, the senior vice president now owns 279,551 shares in the company, valued at $37,733,793.98. The disclosure for this sale can be found here. Company insiders own 2.70% of the company’s stock.

A number of equities analysts have recently commented on the company. Stephens set a $150.00 price objective on HCA Healthcare and gave the stock a “buy” rating in a report on Wednesday, August 7th. Goldman Sachs Group upgraded HCA Healthcare from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $147.00 to $160.00 in a report on Wednesday, July 10th. Zacks Investment Research downgraded HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 price objective on the stock. in a report on Monday, May 27th. UBS Group raised their price objective on HCA Healthcare from $172.00 to $181.00 and gave the stock a “buy” rating in a report on Monday, June 24th. Finally, Mizuho set a $153.00 price objective on HCA Healthcare and gave the stock a “buy” rating in a report on Wednesday, July 31st. Three analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $155.00.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Read More: Systematic Risk

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.